Literature DB >> 25545183

Relevance of age at diagnosis to prevention of late-onset group B streptococcal disease by maternal immunization.

Morven S Edwards1, Marcia A Rench, Carol J Baker.   

Abstract

Among 248 infants with late-onset group B streptococcal (GBS) disease from 1993 to 2012, approximately two thirds (63%) had a gestation of at least 35 weeks and 72% of these became ill within 6 weeks of life (median 27 days), suggesting that third trimester maternal GBS immunization could substantially reduce the late-onset GBS disease burden in the United States.

Entities:  

Mesh：

Year:  2015        PMID： 25545183     DOI： 10.1097/INF.0000000000000640

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  4 in total

1.  Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United States, 2006 to 2015: Multistate Laboratory and Population-Based Surveillance.

Authors:  Srinivas Acharya Nanduri; Susan Petit; Chad Smelser; Mirasol Apostol; Nisha B Alden; Lee H Harrison; Ruth Lynfield; Paula S Vagnone; Kari Burzlaff; Nancy L Spina; Elizabeth M Dufort; William Schaffner; Ann R Thomas; Monica M Farley; Jennifer H Jain; Tracy Pondo; Lesley McGee; Bernard W Beall; Stephanie J Schrag
Journal:  JAMA Pediatr       Date:  2019-03-01       Impact factor: 16.193

Review 2.  Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries.

Authors:  Miwako Kobayashi; Johan Vekemans; Carol J Baker; Adam J Ratner; Kirsty Le Doare; Stephanie J Schrag
Journal:  F1000Res       Date:  2016-09-22

3.  Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM197-Conjugate Vaccine During Pregnancy.

Authors:  Shabir A Madhi; Anthonet Koen; Clare L Cutland; Lisa Jose; Niresha Govender; Frederick Wittke; Morounfolu Olugbosi; Ajoke Sobanjo-Ter Meulen; Sherryl Baker; Peter M Dull; Vas Narasimhan; Karen Slobod
Journal:  Clin Infect Dis       Date:  2017-11-13       Impact factor: 9.079

4.  Protective effect of Group B Streptococcus type-III polysaccharide conjugates against maternal colonization, ascending infection and neonatal transmission in rodent models.

Authors:  Emiliano Chiarot; Angela Spagnuolo; Silvia Maccari; Eleonora Naimo; Alessandra Acquaviva; Raffaella Cecchi; Bruno Galletti; Monica Fabbrini; Elena Mori; Paolo Ruggiero; Guido Grandi; Maria Rita Fontana; Giuliano Bensi; Immaculada Margarit
Journal:  Sci Rep       Date:  2018-02-07       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.